GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Total Operating Expense

PharmaEngine (ROCO:4162) Total Operating Expense : NT$422 Mil (TTM As of Dec. 2024)


View and export this data going back to 2012. Start your Free Trial

What is PharmaEngine Total Operating Expense?

PharmaEngine's Total Operating Expense for the three months ended in Dec. 2024 was NT$141 Mil. PharmaEngine's Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 was NT$422 Mil.

PharmaEngine Total Operating Expense Historical Data

The historical data trend for PharmaEngine's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PharmaEngine Total Operating Expense Chart

PharmaEngine Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 209.07 255.29 321.94 441.79 422.40

PharmaEngine Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111.33 86.04 106.66 89.04 140.66

PharmaEngine Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$422 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PharmaEngine Total Operating Expense Related Terms

Thank you for viewing the detailed overview of PharmaEngine's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

PharmaEngine Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PharmaEngine Inc (ROCO:4162) » Definitions » Total Operating Expense
Comparable Companies
ROCO:4174 ROCO:4728 ROCO:6547 ROCO:6712 ROCO:6617 ROCO:6976 TPE:6541 ROCO:6586 ROCO:6696 TPE:4142 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX XBRU:UCB ALNY ONC BNTX XKRX:068270
Traded in Other Exchanges
N/A
Address
10 Minsheng East Road, 11th Floor, Section 3, Taipei, TWN, 104
Website
https://www.pharmaengine.com
PharmaEngine Inc is a biopharmaceutical company engaged in the development of new drugs and therapeutic drugs for cancer. It is a specialty pharma company that adopts the no research, development-only model and the networked pharma model for new drug development. Its projects pipeline are: ONIVYDE was approved by the U.S. FDA, Taiwan FDA, and EMA for patients with gemcitabine-treated metastatic pancreatic cancer; and PEP07. It generates the revenue from Sales of goods.

PharmaEngine Headlines

No Headlines